GBI Research Reports
GBI Research covers worldwide markets and issues, supplies actionable data and forecasts and is driven by industry leaders' insights. GBI Research provides a broad spectrum of reports across the healthcare and energy industries and its online offering is easy to navigate - a comprehensive resource for business information needs.
Search GBI Research Reports
Latest Reports from GBI Research Reports
| |||||||||||||||||||||||
| Name | Date | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Arthritis Therapeutics Market to 2018 - Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications | May 18, 2012 | ||||||||||||||||||||||
| ...Arthritis Therapeutics Market to #### Novel Oral JAK Inhibitors and Biologic Disease Modifying Anti-Rheumatic Drugs (DMARD) Will Drive Continued Growth Across Key Indications GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be... | |||||||||||||||||||||||
| Antibacterials Market to 2017 - Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential | May 18, 2012 | ||||||||||||||||||||||
| ...Antibacterials Market to #### Innovative Anti-Infectives that Target MDR Gram-Negative Pathogens Offer Significant Revenue Potential GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY #### Page #... | |||||||||||||||||||||||
| Generics in Cardiovascular Diseases Market to 2018 - Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution | May 18, 2012 | ||||||||||||||||||||||
| ...Generics in Cardiovascular Diseases Market to #### Loss of Lipitor Market Exclusivities and Impending Patent Expirations of Plavix to Drive Generic Substitution GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR... | |||||||||||||||||||||||
| Pricing and Reimbursement in Brazil - Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs | May 18, 2012 | ||||||||||||||||||||||
| ...Pricing and Reimbursement in Brazil Health Technology Assessment (HTA) Studies to Facilitate Setting of Ceiling Prices for New Drugs GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY ####... | |||||||||||||||||||||||
| Drug Price Cuts in Top Five Countries of Europe - Tougher Reference Pricing Environment and Drug Price Freeze through 2013 Expected to Drive Down Healthcare Costs | May 18, 2012 | ||||||||||||||||||||||
| ...Drug Price Cuts in Top Five Countries of Europe Tougher Reference Pricing Environment and Drug Price Freeze through #### Expected to Drive Down Healthcare Costs GBI Research Report Guidance © GBI Research. This is a licensed product and is not to... | |||||||||||||||||||||||
| Prescribing Trends in Opioids - Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management | May 18, 2012 | ||||||||||||||||||||||
| ...Prescribing Trends in Opioids Driven by Efficacy Advantages, Opioids to Remain the Mainstay of Breakthrough Pain Management GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published MAY #### Page #... | |||||||||||||||||||||||
| Polyethylene Terephthalate (PET) Global Market to 2020 - Increasing Demand from Carbonated Soft Drinks, Food and Beer Packaging in BRIC Nations Driving Growth | May 18, 2012 | ||||||||||||||||||||||
| ...Polyethylene Terephthalate (PET) Global Market to #### Increasing Demand from Carbonated Soft Drinks, Food and Beer Packaging in BRIC Nations Driving Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBICH####MR... | |||||||||||||||||||||||
| Orphan Disease Therapeutics in Genetic Disorders to 2018 - Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity | May 15, 2012 | ||||||||||||||||||||||
| ...Orphan Disease Therapeutics in Genetic Disorders to #### Emerging Agents in Cystic Fibrosis Offer Strong Opportunities for Investment and Licensing Activity GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIHC###MR / Published... | |||||||||||||||||||||||
| Power Market in SAARC Countries to 2020 - FDI Driven by Private Sector Participation is Key to Future Growth | May 04, 2012 | ||||||||||||||||||||||
| ...Power Market in SAARC Countries to #### FDI Driven by Private Sector Participation is Key to Future Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIPE####MR / Published MAY #### Page... | |||||||||||||||||||||||
| Iron Ore Mining Market in North America to 2020 - Demand for Steel in the US to Boost Regional Iron Ore Production | May 04, 2012 | ||||||||||||||||||||||
| ...Iron Ore Mining Market in North America to #### Demand for Steel in the US to Boost Regional Iron Ore Production GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIMM####MR / Published... | |||||||||||||||||||||||
| Iron Ore Mining Market in Asia-Pacific to 2020 - Interplay Between Regional Demand for Steel and Iron Production Shapes the Competitive Landscape | May 04, 2012 | ||||||||||||||||||||||
| ...Iron Ore Mining Market in Asia-Pacific to #### Interplay Between Regional Demand for Steel and Iron Production Shapes the Competitive Landscape GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIMM####MR... | |||||||||||||||||||||||
| Crude Oil Industry to 2016 - Deepwater Discoveries Worldwide and Rising Industrial Demand in Emerging Economies Driving the Industry | May 04, 2012 | ||||||||||||||||||||||
| ...Crude Oil Industry to #### Deepwater Discoveries Worldwide and Rising Industrial Demand in Emerging Economies Driving the Industry GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIGE#####MR / Published MAY #### Page... | |||||||||||||||||||||||
| Natural Gas Industry to 2017 - Depleting Conventional Crude Oil Reserves and Emerging Technologies in Gas Consumption Infrastructure Driving Growth | May 04, 2012 | ||||||||||||||||||||||
| ...Natural Gas Industry to #### Depleting Conventional Crude Oil Reserves and Emerging Technologies in Gas Consumption Infrastructure Driving Growth GBI Research Report Guidance © GBI Research. This is a licensed product and is not to be photocopied GBIGE#####MR / Published MAY ####... | |||||||||||||||||||||||
| Oil and Gas Enhanced Production Services Industry to 2016 - Enhanced Oil Recovery (EOR) Driving E&P Activity in Depleting Hydrocarbon Reservoirs | May 01, 2012 | ||||||||||||||||||||||
| ...Oil and Gas Enhanced Production Services Industry to #### - Enhanced Oil Recovery (EOR) Driving E&P Activity in Depleting Hydrocarbon Reservoirs GBIGE#####MR /Published MAY #### Page # © GBI Research. This report is a licensed product and is not to be... | |||||||||||||||||||||||
| Oral Drug Delivery Market to 2017 - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth | Apr 30, 2012 | ||||||||||||||||||||||
| ...Oral Drug Delivery Market to #### - Out-licensing Proprietary Technologies for Proteins, Peptides and Small Molecules to Drive Revenue Growth GBIHC###MR /Published APR #### Page # © GBI Research. This report is a licensed product and is not to be copied... | |||||||||||||||||||||||
| Orphan Disease Therapeutics Market to 2018 - Improved Understanding of Rare Diseases' Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation | Apr 30, 2012 | ||||||||||||||||||||||
| ...Orphan Disease Therapeutics Market to #### - Improved Understanding of Rare Diseases Heterogeneity and Novel New Clinical Trial Designs to Foster Innovation GBIHC###MR /Published APR #### Page # © GBI Research. This report is a licensed product and is not to be... | |||||||||||||||||||||||
| Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall | Apr 30, 2012 | ||||||||||||||||||||||
| ...Regulatory Intelligence on Medical Device Recalls - Ineffective Process Control, Defects in Design of Device, Software or Other Components are the Major Reasons for Recall GBIHC###MR /Published APR #### Page # © GBI Research. This report is a licensed product and is... | |||||||||||||||||||||||
| Cytotoxic Therapies Market to 2017 - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion | Apr 30, 2012 | ||||||||||||||||||||||
| ...Cytotoxic Therapies Market to #### - Launch of Next Generation Camptothecin Analogues Will Help Offset Revenue Loss due to Generic Erosion GBIHC###MR / Published APR #### Page # © GBI Research. This report is a licensed product and is not to be copied... | |||||||||||||||||||||||
| Orphan Diseases Therapeutics in Oncology to 2018 - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules | Apr 30, 2012 | ||||||||||||||||||||||
| ...Orphan Diseases Therapeutics in Oncology to #### - Strongly Diversified Developmental Pipelines Indicate Long-Term Growth Potential despite Moderate Scope of Current Late Stage Molecules GBIHC###MR /Published APR #### Page # © GBI Research. This report is a licensed product and is... | |||||||||||||||||||||||
| Autoimmune Disorders Therapeutics Market to 2017 - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments | Apr 30, 2012 | ||||||||||||||||||||||
| ...Autoimmune Disorders Therapeutics Market to #### - Launch of Gilenya and Benlysta to Drive the Growth of Multiple Sclerosis and Systemic Lupus Erythematosus Therapeutic Segments GBIHC###MR /Published APR #### Page # © GBI Research. This report is a licensed product and is... | |||||||||||||||||||||||
